EPISODE · Nov 25, 2022 · 8 MIN
Papers Unplugged: CHIP and Associated Risk in Elderly Patients
from EHA Unplugged · host European Hematology Association
What is clonal hematopoiesis of indeterminate potential (CHIP) and its associated risks in elderly patients?Join our guest Prof Kirsten Gronbaek and host Dr Christian Scharenberg as they discuss CHIP, its biological significance, frequency in the general population, and its association with epigenetic age. Listen along as Prof Gronbaek dives deeper into the subject and explains the association and significance of CHIP with mutations and patient survival. Last but not least, Prof Gronbaek talks about the challenges and current landscape of trials and studies on treatment for CHIP.This discussion is based on the recently published article Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins in HemaSphere.Host: Dr Christian Scharenberg; Guest: Professor Kirsten GronbaekThis is the third of a series of podcasts discussing recently published scientific articles. More podcasts will be available in the future. Stay tuned! Learn MoreWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more eLearning or podcasts? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: [email protected] to receive the EHA Educational Updates via https://eha.news/subscribe
What this episode covers
What is clonal hematopoiesis of indeterminate potential (CHIP) and its associated risks in elderly patients?Join our guest Prof Kirsten Gronbaek and host Dr Christian Scharenberg as they discuss CHIP, its biological significance, frequency in the general population, and its association with epigenetic age. Listen along as Prof Gronbaek dives deeper into the subject and explains the association and significance of CHIP with mutations and patient survival. Last but not least, Prof Gronbaek talks about the challenges and current landscape of trials and studies on treatment for CHIP.This discussion is based on the recently published article Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins in HemaSphere.Host: Dr Christian Scharenberg; Guest: Professor Kirsten GronbaekThis is the third of a series of podcasts discussing recently published scientific articles. More podcasts will be available in the future. Stay tuned! Learn MoreWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more eLearning or podcasts? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: [email protected] to receive the EHA Educational Updates via https://eha.news/subscribe
NOW PLAYING
Papers Unplugged: CHIP and Associated Risk in Elderly Patients
No transcript for this episode yet
Similar Episodes
Jun 24, 2026 ·20m
Jun 23, 2026 ·28m
Jun 23, 2026 ·10m
Jun 22, 2026 ·20m
Jun 19, 2026 ·70m